The Effect of Breastfeeding Counselling with Motivational Inter-viewing Technique on Breastfeeding Problems and Anxiety
Launched by SEMIHA IZGORDU · Nov 26, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The data elements to be used in the study are as follows:
'Personal Information Form (Appendix-1)', "Breastfeeding Problems Assessment Scale (Appendix-2)" to determine the problems experienced by mothers regarding breastfeeding, and "State Anxiety Scale (Appendix-3)" to determine the anxiety level of mothers will be used to collect the data. 'Informed Consent Form (Appendix-4)' will be filled in and permission to participate in the study will be obtained.
Appendix 1- Personal Information Form A personal information form was prepared by reviewing the literature (Gölbaşı et al.) The informa...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Having a healthy 1-3 month old baby
- • Being identified as having a breastfeeding problem
- • To be at least primary school graduate
- • To be able to communicate by telephone
- • To come to the Family Health Centre for motivational talks
- Exclusion Criteria:
- • Having a baby with anomalies
- • Having a baby younger than 1 month and older than 3 months
- • Having a medical illness that prevents breastfeeding
- • Communication problems
- • Not accepting motivational interviewing
- • The presence of any psychiatric illness
About Semiha Izgordu
Semiha Izgordu is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong focus on innovative therapeutic solutions, the organization collaborates with researchers, healthcare professionals, and regulatory bodies to design and implement rigorous clinical trials. Semiha Izgordu emphasizes ethical standards and patient safety, ensuring that all trials are conducted with the highest level of integrity and compliance. Their expertise spans various therapeutic areas, making significant contributions to the development of new treatments and enhancing the understanding of disease management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Tuzla, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported